In our previous study, we demonstrated that mutations of eight members of the ADAMTS family (including ADAMTS16 gene) were significantly associated with chemotherapy sensitivity and longer survival in patients with ovarian cancer, independent of BRCA1 or BRCA2 mutations [11]. Here, BRCA1 is linked to ovarian carcinoma.